Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex-Reference-Cited by-同舟云学术

Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex

Published:2018-07-01 Issue:7 Volume:154 Page:781
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Wataya-Kaneda Mari¹,Ohno Yuuki²,Fujita Yasuyuki³,Yokozeki Hiroo⁴,Niizeki Hironori⁵,Ogai Masaaki⁶,Fukai Kazuyoshi⁷,Nagai Hiroshi⁸,Yoshida Yuichi⁹,Hamada Izumi¹⁰,Hio Taihei¹⁰,Shimizu Kenji¹⁰,Murota Hiroyuki¹

Affiliation:

1. Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka, Japan

2. Department of Dermatology, JR Tokyo General Hospital, Tokyo, Japan

3. Department of Dermatology, Hokkaido University Graduate School of Medicine, Hokkaido, Japan

4. Department of Dermatology, Medical Hospital, Tokyo Medical and Dental University, Tokyo, Japan

5. Division of Dermatology, Department of Surgical Subspecialties, National Center for Child Health and Development, Tokyo, Japan

6. Department of Dermatology, Seirei Hamamatsu General Hospital, Shizuoka, Japan

7. Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan

8. Division of Dermatology, Department of Internal Related, Kobe University Graduate School of Medicine, Hyogo, Japan

9. Division of Dermatology, Department of Medicine of Sensory and Motor Organs, Faculty of Medicine, Tottori University, Tottori, Japan

10. Nobelpharma Co, Ltd, Tokyo, Japan

Publisher

American Medical Association (AMA)

Subject

Dermatology

Reference26 articles.

1. Tuberous sclerosis complex: advances in diagnosis, genetics, and management.;Schwartz;J Am Acad Dermatol,2007

2. The cutaneous features of tuberous sclerosis: a population study.;Webb;Br J Dermatol,1996

3. Trends in the prevalence of tuberous sclerosis complex manifestations: an epidemiological study of 166 Japanese patients.;Wataya-Kaneda;PLoS One,2013

4. Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.;Haemel;Arch Dermatol,2010

5. A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity.;Wataya-Kaneda;Br J Dermatol,2011

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside;Applied Materials Today;2024-08

2. The effect of autophagy on hemoporfin-mediated photodynamic therapy in human umbilical vein endothelial cells;Photodiagnosis and Photodynamic Therapy;2024-06

3. Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results;Annals of the Child Neurology Society;2024-04-22

4. Validation of the Index for Facial Angiofibromas: Data analysis from a randomized controlled trial of sirolimus gel treatment in patients with tuberous sclerosis complex;The Journal of Dermatology;2024-04-15

5. Principles of Cutaneous Laser Therapy;Rook's Textbook of Dermatology;2024-02-20